Cambridge Healthtech Institute’s 14th Annual
Formulation, Stability & Delivery
Optimizing Biotherapeutic Performance through Innovative Science and Technologies
June 15-16, 2027
Cambridge Healthtech Institute’s 14th annual conference brings together leading industry and academic experts to advance formulation, stability, and delivery strategies for traditional and next-generation biotherapeutics. Explore innovative approaches to address the challenges of complex modalities, optimize high- and low-concentration formulations, and integrate formulation design with patient-centric delivery. Discover how AI, predictive modeling, high-throughput screening, and advanced analytics are accelerating development and strengthening product understanding. Join us in June, 2027 to exchange best practices, network with peers, and develop robust drug products that meet evolving patient and regulatory needs.
Coverage will include, but is not limited to:
- Optimizing high- and low-concentration formulations, addressing viscosity, solubility, injectability, and low-dose delivery challenges
- Advancing formulation and developability strategies for complex modalities, including multispecific antibodies, antibody-drug conjugates, and co-formulations
- Leveraging AI, machine learning, and mechanistic modeling to predict viscosity, aggregation, and stability, and to guide formulation selection
- Accelerating formulation development through automation, high-throughput screening, design of experiments, and integrated data analysis
- Preventing protein aggregation and particle formation through advanced characterization and risk-based strategies to support product quality and safety
- Managing host-cell proteins, trace metals, and polysorbate degradation through improved detection, characterization, and control strategies
- Exploring novel excipients and alternative surfactants to enhance stability and product performance within regulatory frameworks
- Advancing stability assessment through predictive kinetic modeling, forced-degradation studies, and lyophilization strategies to support shelf life and storage flexibility
- Developing patient-centric subcutaneous delivery solutions, including high dose and large volume administration, autoinjectors, and wearable devices
- Understanding formulation, container–closure, and device interactions to ensure compatibility, stability, and reliable delivery
The deadline for priority consideration is November 20, 2026.
All proposals are subject to review by session chairpersons and/or the Scientific Advisory Committee to ensure the overall quality of the conference program. Additionally, as per Cambridge Healthtech Institute’s policy, a select number of vendors and consultants who provide products and services will be offered opportunities for podium presentation slots based on a variety of Corporate Sponsorships.
Opportunities for Participation:
- To submit a podium presentation, please click here.
- To become a sponsor, click here.
- To present a poster, click here.
- To sign up to attend, click here.